28
5
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2010 |
S0859
|
Others | Others |
S0859 是一种 N-氰基磺酰胺,是选择性高亲和力的 Na+/HCO3-共转运体抑制剂,可逆性地抑制 NBC 介导的细胞内 pH (pHi) 恢复,Ki 为1.7 μM。 | |||
T38843 |
Enavogliflozin
DWP-16001 |
SGLT | GPCR/G Protein |
Enavogliflozin (DWP-16001) 是一种口服有效的,选择性的钠-葡萄糖协同转运体 -2 抑制剂,具有抗糖尿病的功效。 | |||
TQ0011 |
PF-06869206
|
Sodium Channel | Membrane transporter/Ion channel |
PF-06869206 是口服有效的磷酸钠协同转运蛋白NaPi2a(SLC34A1) 选择性抑制剂,IC50为 380 nM。 | |||
T17243 |
VU0463271
N-Cyclopropyl-N-(4-methyl-2-thiazolyl)-2-[(6-phenyl-3-pyridazinyl)thio]acetamide |
Potassium Channel | Membrane transporter/Ion channel |
VU0463271 (N-Cyclopropyl-N-(4-methyl-2-thiazolyl)-2-[(6-phenyl-3-pyridazinyl)thio]acetamide) 是一种有效的、特异性的 KCC2 拮抗剂,其 IC50 为 61 nM,特异性是密切相关的 Na-K-2Cl 协同转运蛋白 1 (NKCC1) 的 100 倍以上,在更大的 GPCR、离子通道和转运蛋白面板中没有活性。 | |||
T4999 |
Ertugliflozin
埃格列净,MK-8835,PF-04971729 |
SGLT | GPCR/G Protein |
Ertugliflozin (PF-04971729) 是选择性的、口服有效的钠离子依赖的葡萄糖协同转运蛋白2 (SGLT2) 抑制剂,对h-SGLT2 的IC50值为 0.877 nM。Ertugliflozin 在2型糖尿病中有研究价值。 | |||
TQ0139 |
VU 0240551
N-(4-Methyl-2-thiazolyl)-2-[(6-phenyl-3-pyridazinyl)thio]acetamide,VU0240551-2-D4 |
Potassium Channel; Calcium Channel; HER | Angiogenesis; JAK/STAT signaling; Membrane transporter/Ion channel; Metabolism; Tyrosine Kinase/Adaptors |
VU 0240551 是神经元 K-Cl 协同转运蛋白 KCC2 抑制剂的特异性拮抗剂,IC50 为 560 nM。 VU 0240551 抑制 L 型钙通道和 hERG。 | |||
T5444 |
CLP290
CLP-290 |
Potassium Channel | Membrane transporter/Ion channel |
CLP-290 是一种神经特异性 K+-Cl−共转运体 KCC2的口服激活剂,在多种神经和精神疾病方面具有研究潜力。CLP290 能显著降低 STZ 大鼠的血液中 AVP 和血糖水平。 | |||
T14984 |
CLP257
|
Potassium Channel | Membrane transporter/Ion channel |
CLP257 是有效的 K+-Cl- 协同转运蛋白 KCC2 选择性激活剂 (EC50: 616 nM)。它可减轻神经性疼痛大鼠的超敏反应,并在翻译后调节质膜 KCC2 蛋白周转。它在 KCC2 活性降低的神经元中恢复受损的 Cl- 转运。 | |||
T4564 |
Ethacrynic acid
Edecrin,利尿酸,Etacrynic Acid,Hydromedin |
Others; Calcium Channel; NF-κB; GST | Membrane transporter/Ion channel; Metabolism; NF-κB; Others; oxidation-reduction |
Ethacrynic acid (Edecrin) 是谷胱甘肽 S-转移酶抑制剂,也是NF-κB 信号传导途径的有效抑制剂,并且还调节白三烯的形成。它还可抑制 L 型电压依赖性和储存操作的钙通道,从而导致气道平滑肌细胞松弛。它是利尿剂,具有抗炎特性,可减轻类维生素 A 诱导的小鼠耳部水肿。 | |||
T35336 |
Furosemide sodium
Frusemide Sodium,Lasix |
Na-K-Cl cotransporter | Membrane transporter/Ion channel |
Furosemide sodium (Frusemide Sodium) 是 Na+/K+/2Cl- (NKCC),NKCC1 和 NKCC2 共转运蛋白的有效的和具有口服活性抑制剂。Furosemide sodium 也是 GABAA 受体拮抗剂,对含 α6 受体的选择性是含 α1 受体的 100 倍。Furosemide sodium 用作利尿试剂,用于充血性心力衰竭,高血压和水肿的研究。 | |||
T21399 |
Luseogliflozin
TS71,TS-071,TS 71,TS071,TS-71,TS 071 |
||
Luseogliflozin, a potent and competitive inhibitor of sodium-dependent glucose cotransporter 2 (SGLT2), competitively inhibits human SGLT2-mediated glucose uptake with a Ki value of 1.10 nM. | |||
T16818 | S-8921 | Others | Others |
S-8921 is an inhibitor of ileal Na+/bile acid cotransporter. | |||
T17221 |
Velagliflozin
|
SGLT | GPCR/G Protein |
Velagliflozin is an orally available inhibitor of sodium-glucose cotransporter 2. | |||
T13179 |
Tofogliflozin
CSG452 |
Others | Others |
Tofogliflozin is a highly specific inhibitor of sodium/glucose cotransporter 2 (SGLT2) (Kis: 2.9, 14.9, and 6.4 nM for human, rat, and mouse SGLT2. IC50s: 2.9/14.9/6.4 nM (human/rat/mouse SGLT2)). | |||
T11528 |
H100
|
Others | Others |
H100 is a Cl- transport inhibitor, no effect against KCl cotransporter. It has partial effects against both the NaK2Cl cotransporter and the Band 3 anion exchanger. | |||
T30534 |
BMS-639432
|
||
BMS-639432 is a potent sodium-glucose cotransporter type II (SGLT2) inhibitor. | |||
T15752 |
Licogliflozin
LIK066 |
SGLT | GPCR/G Protein |
Licogliflozin (LIK066) 是钠-葡萄糖协同转运蛋白 (SGLT1和SGLT2) 的有效抑制剂。 | |||
T28971 |
Tianagliflozin
|
||
Tianagliflozin, a sodium/glucose cotransporter 2 (SGLT-2) inhibitor, is used potentially for the treatment of type 2 diabetes. | |||
T61713 |
Bumetanide sodium
|
||
Bumetanide sodium is a potent loop diuretic that acts as a blocker for the sodium-potassium-chloride cotransporter (NKCC). It selectively inhibits NKCC1 and NKCC2, with IC50 values of 0.68 μM and 4.0 μM for hNKCC1A and hNKCC2A, respectively [1] [2]. | |||
T12892 |
SGL5213
|
SGLT | GPCR/G Protein |
SGL5213 is an oral active and low-absorbable inhibitor of sodium-dependent glucose cotransporter 1 (SGLT1)(hSGLT1 and hSGLT2 with IC50 values of 29 nM and 20 nM , respectively),and has potential to treat type 2 diabetes. | |||
T68236 |
TP0438836
|
||
TP0438836 is a potent, low-absorbable sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor for the treatment of type 2 diabetes. TP0438836 showed IC50 values 28nM and 7 nM for hSGLT1 and hSGLT2 resepctively. | |||
T15797 |
LX2761
|
Others | Others |
LX2761 is a chemically stable and effective inhibitor against sodium-dependent glucose cotransporter 1 (SGLT1) and SGLT2 (IC50s: 2.2 nM and 2.7nM for hSGLT1 and hSGLT2). However, it shows specific SGLT1 inhibition in the gastrointestinal (GI) tract. | |||
T35728 |
Hydrochlorothiazide Impurity C
|
||
Hydrochlorothiazide impurity C is a potential impurity found in commercial hydrochlorothiazide preparations. [1] Hydrochlorothiazide is a thiazide diuretic that inhibits the apical membrane sodium chloride cotransporter in the distal and collecting duct nephron segments.[2][3][4] | |||
T35619 |
Dapagliflozin-3-O-β-D-Glucuronide
|
||
Dapagliflozin-3-O-β-D-glucuronide is a metabolite of dapagliflozin . Dapagliflozin is a first generation selective sodium glucose cotransporter (SGLT) 2 inhibitor that blocks glucose transport.[1] Dapagliflozin is metabolized by uridine diphosphate glucuronosyltransferase (UGT) 1A9 to dapagliflozin-3-O-β-D-glucuronide, which is 2,600-fold less potent than the parent compound with regard to SGLT2 inhibition.[2] | |||
T68922 |
YM543 free base
|
||
YM543 free base 为口服有效的钠-葡萄糖协同转运蛋白(SGLT) 2抑制剂,主要用于降低血糖水平,适用于糖尿病研究。 | |||
T72143 |
Velagliflozin proline hydrate
|
||
Velagliflozin proline hydrate 是 Velagliflozin 的临床形式。Velagliflozin 是一种可口服的钠-葡萄糖协同转运蛋白 2 (SGLT2) 抑制剂,具有抗糖尿病的活性。 特别是,Velagliflozin 减少肾葡萄糖重吸收,促进葡萄糖尿,从而降低血糖和胰岛素浓度。 | |||
T70390 |
YM-543 choline
|
||
YM-543, also known as ASP-543, is a selective SGLT2 inhibitor. Sodium-glucose cotransporter 2 (SGLT2) is a specifically expressed transporter in the kidney that plays an important role in renal glucose reabsorption, and its inhibition may present a novel therapeutic strategy for treating diabetes. YM543 potently and selectively inhibited mouse and human SGLT2 activities at nanomolar ranges. In vivo single oral administration of YM543 dose-dependently and significantly reduced blood glucose level... | |||
T35876 |
Chlorthalidone Impurity G
|
||
Chlorthalidone impurity G is a potential impurity found in commercial preparations of chlorthalidone that has moderate antihypertensive effects. Chlorthalidone is a thiazide-like diuretic that inhibits the Na+/Cl- cotransporter in the distal convoluted tubule of the kidney, which prevents reabsorption of sodium and chloride leading to a reduction in plasma volume and cardiac output. It also inhibits carbonic anhydrase (CA), including the isoforms CAVB, VII, IX, XII, and XIII (Kis = 2.8-23 nM) an... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN1847 |
Kushenol X
苦参醇X |
Others | Others |
Kushenol X exhibits inhibitory activity against Sodium-dependent glucose cotransporter 2(SGLT2). | |||
TN1841 |
Kushenol A
苦参新醇 A,Leachianone E |
cAMP | GPCR/G Protein |
Kushenol A is a kind of Adenosine 3', 5'-cyclic monophosphate(cAMP)phosphodiesterase inhibitiors, it shows selective alpha-glucosidase inhibitory activity. Kushenol A and kushenol C exhibit inhibitory activity against Sodium-dependent glucose cotransporter 2(SGLT2). | |||
TN1842 |
Kushenol I
|
GABA Receptor; Antifection | Membrane transporter/Ion channel; Microbiology/Virology; Neuroscience |
Kushenol I is a GABAA receptor modulator, it exhibits inhibitory activity against Sodium-dependent glucose cotransporter 2(SGLT2).Kushenol I is shown to be active against the plant pathogenic fungus Cladosporium cucumerinum. | |||
TN4399 | Kushenol C | SGLT; NF-κB; ROS; BACE; Antifection | GPCR/G Protein; Immunology/Inflammation; Microbiology/Virology; Neuroscience; NF-κB |
Kushenol C is a good 1,1-diphenyl-2-picrylhydrazyl (DPPH) scavenger, and it exhibits inhibitory activity against Sodium-dependent glucose cotransporter 2(SGLT2). Kushenol C shows antimicrobial activity against Staphylococcus aureus and Streptococcus mutan | |||
TN2553 |
1-Methyl-2-undecyl-4(1H)-quinolone
1-Methyl-2-undecylquinolin-4(1H)-one |
MAO | Metabolism; Neuroscience |
1-Methyl-2-undecyl-4(1H)-quinolone, and dihydroevocarpine should also be served as the chemical markers together with evodiamine for the quality control of Evodia rutaecarpa (Juss.) Benth. 1-Methyl-2-undecyl-4(1H)-quinolone shows a selective inhibition of type B MAO (MAO-B) activity with the IC(50) value of 15.3 microM using a substrate kynuramine, but does not inhibit type A MAO (MAO-A) activity.It can mitigate high phosphate-induced human aortic valve interstitial cells (HAVICs) calcification ... |